5.83 USD
↗ 0.00 (0.00%)AT CLOSE (11:59 AM EDT)
Savara Inc.
SVRANASDAQ • USD
5.75
↘ 0.08 (1.36%)
POST MARKET (AS OF 07:37 PM EDT)
Post Market
AS OF 07:37 PM EDT
5.75
↘ 0.08 (1.36%)
Market: CLOSED
Savara Inc. (SVRA) trades at $5.82 per share. The stock presents a mixed profile: our models indicate a Strong Buy for technical indicators, while underlying fundamentals flash a Sell. Key drivers include a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bullish Golden Cross on the moving averages and bullish moving average alignment. SVRA is fairly valued relative to its sector peers based on current multiples.
Technical & fundamental data as of Aug 7, 2026.
Open?$5.87
High?$5.99
Low?$5.79
Prev. Close?$5.83
Volume?1.6M
Avg. Volume?1.9M
VWAP?$5.85
Rel. Volume?0.85x
Bid / Ask
Bid?$5.50 × 400
Ask?$6.06 × 1.0K
Spread?$0.56
Midpoint?$5.78
Valuation & Ratios
Market Cap?1.2B
Shares Out?204.9M
Float?146.5M
Float %?71.5%
P/E Ratio?N/A
P/B Ratio?6.79
EPS?-$0.63
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Savara Inc is a clinical-stage biopharmaceutical company. It is focused on rare respiratory diseases. It has one segment specialty pharmaceuticals within the respiratory system. The company's main product candidate, molgramostim, is an inhaled granulocyte-macrophage colony-stimulating factor (GM-CSF) in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP).
Employees
70
Market Cap
1.2B
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
1996-11-18
Address
6836 BEE CAVE ROAD
AUSTIN, TX 78746
Phone: 51285113796
AUSTIN, TX 78746
Phone: 51285113796
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+2/3)
Medium-Term (Wave)?▲ Bullish(+3/3)
Short-Term (Ripple)?▲ Bullish(+3/3)
MA Alignment?Golden Alignment
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?100
Momentum?50
Short Sent.?14
Piotroski F-Score?0/9Weak
Altman Z-Score?10.69Safe
Confidence?45%Low
Short InterestSqueeze Risk
Short % of Float?23.31%Squeeze Risk
Short Interest?34.1M
Days to Cover?20.8
Free Float146.5M
Avg Daily Volume1.6M
Settlement Date2026-07-15
Financial Health
Current Ratio?13.47Strong
Quick Ratio?13.47Strong
Cash Ratio?2.50Strong
Debt/Equity?0.17Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score83/100
P/E?N/A▾
P/B?6.79FAIR▾
Peers100
S&P27
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-8.9CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-73.6%WEAK▾
S&P3
ROA?-58.4%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-106967000
Enterprise Value?$1.2B
Fundamentals ratios updated end of day